期刊文献+
共找到260篇文章
< 1 2 13 >
每页显示 20 50 100
Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma 被引量:2
1
作者 Kim Vaiphei Aruna Rangan Rajinder Singh 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2012年第12期250-258,共9页
AIM:To characterize aberrant crypt focus (ACF) in adjoining mucosa in sporadic colorectal carcinoma and to evaluate fragile histidine triad (Fhit) protein and Ki67. METHODS:ACF was identified grossly and classified hi... AIM:To characterize aberrant crypt focus (ACF) in adjoining mucosa in sporadic colorectal carcinoma and to evaluate fragile histidine triad (Fhit) protein and Ki67. METHODS:ACF was identified grossly and classified histologically in 75 resected specimens. ACF was typed into hyperplastic ACF (HACF) and dysplastic ACF (DACF). Sections of ACF, carcinoma and normal colonic mucosa as control were studied for Fhit and Ki67 expressions by immunohistochemistry and were grouped according to staining intensity and the number of positive stained cells observed in different histological groups. Comparison was done between the different groups by Pearson's χ 2 test and γ test for the ordinal data. P value < 0.05 was considered as significant.RESULTS:Age range was 40 to 86 years in males (mean = 43.36) and 45 to 70 years in females (mean = 56). HACF was identified in all cases studied in the non-tumorous colonic mucosa; ACF was observed as non-contiguous scattered foci, which supports the hypothesis of acquisition of single focus monoclonality by colonic epithelial cells in tumor generation. Twenty-four (32%) had DACF and were observed as closure to carcinoma foci. Intensity of Fhit expression:(1) HACF 40% exhibited strong intensity, similar to normal, moderate in 36% and weak in 24%; (2) DACF strong in 25%, moderate in 37.5% and weak in 37.5%; and (3) carcinoma negative in 16%, strong in 43% and moderate and weak in 28.5% each. Significant difference was observed in intensity of the Fhit protein expressions by HACF and DACF (P < 0.05). Tumor in older patients showed a stronger Fhit intensity compared to younger patients (P = 0.036). Vegetarian diet intake and nonsmokers showed stronger Fhit intensities. Advanced stage tumor, non-vegetarian diet and younger age was associated with loss of Fhit protein. Ki67 positivity was an extended crypt pattern in HACF and DACF showed extension up to the neck region of the crypts and surface epithelium. Carcinomas showed a marked increase in Ki67 expression (P < 0.05). Fhit protein had an inverse association with Ki67 expression. CONCLUSION:Weaker Fhit intensity was associated with smoking, non-vegetarian diet intake and increasing Ki67 expression. Loss of Fhit protein expression is possibly influenced by environmental factors like smoking and non-vegetarian diet intake. 展开更多
关键词 ABERRANT CRYPT FOCUS Carcinogenesis Colorectal carcinoma Dysplasia fragile histidine triad PROTEIN Ki67
下载PDF
Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas 被引量:1
2
作者 Ji-Yun Lee 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第33期4522-4532,共11页
AIM: To investigate the genomic copy number alterations that may harbor key driver genes in gastric tumorigenesis. METHODS: Using high-resolution array comparative genomic hybridization (CGH), we investigated the geno... AIM: To investigate the genomic copy number alterations that may harbor key driver genes in gastric tumorigenesis. METHODS: Using high-resolution array comparative genomic hybridization (CGH), we investigated the genomic alterations of 20 advanced primary gastric adenocarcinomas (seventeen tubular and three mucinous) of Chinese patients from the Jilin province. Ten matching adjacent normal regions from the same patients were also studied. RESULTS: The most frequent imbalances detected in these cancer samples were gains of 3q26.31-q27.2, 5p, 8q, 11p, 18p, 19q and 20q and losses of 3p, 4p,18q and 21q. The use of high-resolution array CGH increased the resolution and sensitivity of the observed genomic changes and identified focal genetic imbalances, which included 54 gains and 16 losses that were smaller than 1 Mb in size. The most interesting focal imbalances were the intergenic loss/homozygous deletion of the fragile histidine triad gene and the amplicons 11q13, 18q11.2 and 19q12, as well as the novel amplicons 1p36.22 and 11p15.5. CONCLUSION: These regions, especially the focal amplicons, may harbor key driver genes that will serve as biomarkers for either the diagnosis or the prognosis of gastric cancer, and therefore, a large-scale investigation is recommended. 展开更多
关键词 Array comparative genomic hybridization Amplicon Gastric adenocarcinoma Oncogene fragile histidine triad
下载PDF
Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis 被引量:33
3
作者 Ke-JunNan Zhi-PingRuan +4 位作者 ZhaoJing Hai-XiaQin Hong-YanWang HuiGuo RuiXu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第2期228-231,共4页
AIM: To evaluate the expression of fragile histidine triad (FHIT) gene protein, product of a candidate tumor suppressor, and to investigate the relationship between FHIT, cell apoptosis and proliferation, and patholog... AIM: To evaluate the expression of fragile histidine triad (FHIT) gene protein, product of a candidate tumor suppressor, and to investigate the relationship between FHIT, cell apoptosis and proliferation, and pathological features of primary hepatocellular carcinoma (HCC). METHODS: Forty-seven HCC and ten normal liver specimens were collected during surgical operation between 2001 and 2003. FHIT and proliferating cell nuclear antigen (PCNA) expression were detected by immunohistochemistry, and apoptotic level was evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay on the tissue sections. RESULTS: All normal liver tissues showed a strong expression of FHIT, whereas 28 of 47 (59.6%) carcinomas showed a significant loss or absence of FHIT expression (P= 0.001). The proportion of reduced FHIT expression in those carcinomas at stages Ⅲ-Ⅳ (70.6%) and in those with extrahepatic metastasis (86.7%) showed an increasing trend compared with those at stages HI (30.8%, P= 0.013) and those without metastasis (46.9%, P = 0.010) respectively. Apoptotic incidence in advanced TNM stage carcinoma and those with positive FHIT expression was higher than that in early stage carcinoma (P=0.030) and in those with negative FHIT expression (P=0.044) respectively. The proliferating potential of hepatocellular carcinoma was associated with FHIT expression (P= 0.016) and the aggressive feature (P = 0.019). Kaplan-Meier analysis demonstrated that the survival time of these 47 patients correlated with TNM stage, FHIT expression and metastasis. CONCLUSION: There is marked loss or absence of FHIT expression, as well as abnormal apoptosis-prdiferation balance in HCC. FHIT may play an important role in carcinogenesis and development of HCC. 展开更多
关键词 Hepatocellular carcinoma fragile histidine triad protein Cell proliferation APOPTOSIS
下载PDF
Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition 被引量:12
4
作者 Jie Cao Xiao-Ping Chen +7 位作者 Wang-Lin Li JieXia Hong Du Wei-Biao Tang Hui Wang Xi-Wen then Huan-Qing Xiao Yu-Yuan Li 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第7期1018-1026,共9页
AIM: To detect the expression of fragile histidine triad (FHIT) in normal colorectal tissue, colorectal adenoma and colorectal cancer (CRC) tissue, and to analyze its relationship with the clinicopathological fea... AIM: To detect the expression of fragile histidine triad (FHIT) in normal colorectal tissue, colorectal adenoma and colorectal cancer (CRC) tissue, and to analyze its relationship with the clinicopathological features of CRC, and apoptosis-associatecl proteins (Bcl-2, Bax, survivin) and apoptosis in colorectal cancer. METHODS: FHIT mRNA analysis was performed by nested reverse transcription-polymerase chain reaction (RT-PCR) assay. Tissue microarray (TMA) was established to detect the expression of FHIT, Bcl-2, Bax and survivin genes in 80 CRC tissue specimens, 16 colorectal adenoma tissue specimens and 16 hemorrhoid (PPH) tissue specimens during the same period of time as the control. Citrate-microwave-SP was used as immunohistochemical method. The relationship between clinicopathological factors, such as differentiation grades and 5-year survival rate was observed. TUNEL assay was used to detect the apoptosis index in 80 CRC tissue specimens. RESULTS: Ten out of 26 (38.5%) CRC tissue specimens expressed aberrant FHIT transcripts, none of the aberrant FHIT transcripts was observed in the matchednormal tissue and colorectal adenoma tissue by nested RT-PCR assay. The positive rate of FHIT gene expression in normal colorectal tissue, colorectal adenoma and carcinoma tissue was 93.75%, 68.75% and 46.25%, respectively. Clinicopathological analysis of patients showed that the decreased FHIT gene expression was not associated with age, sex, serum CEA levels, tumor site and size, histological classification. However, the expression of FHIT was correlated with differentiation grades, pathological stages, lymph node metastases and 5-year survival rate after operation. The positive rate of apoptosis-associated proteins (Bax, Bcl-2 and survivin) in CRC tissue was 72.50%, 51.25% and 77.50%, respectively. The expression of these apoptosisassociated proteins in CRC tissue was correlated with the expression of FHIT. The mean apoptosis index in FHIT negative tumors was significantly lower than that in FHIT- positive tumors (5.41 ± 0.23 vs 0.56 ± 0.10, P 〈 0.01). CONCLUSION: The FHIT gene plays an important role in the regulation of apoptosis and decreased FHIT expression plays a key role in the initiation and progression of colorectal carcinoma. 展开更多
关键词 Colorectal cancer fragile histidine triad EXPRESSION APOPTOSIS
下载PDF
Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells 被引量:4
5
作者 Rong-Hua Xu Liang-Yan Zheng +7 位作者 Dong-Lei He Jian Tong Li-Ping Zheng Wu-Ping Zheng Jin Meng Li-Ping Xia Cong-Jun Wang Ji-Lin Yi 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第23期3754-3758,共5页
AIM:To evaluate the inhibitory effects of human fragile histidine triad(FHIT) gene on cell proliferation and apoptosis in human hepatocellular carcinoma line Hep3B in vitro. METHODS:A recombinant pcDNA3.1(+) /FHIT inc... AIM:To evaluate the inhibitory effects of human fragile histidine triad(FHIT) gene on cell proliferation and apoptosis in human hepatocellular carcinoma line Hep3B in vitro. METHODS:A recombinant pcDNA3.1(+) /FHIT including the functional region of FHIT gene was constructed and transferred into human hepatocellular carcinoma cells in vitro. mRNA and protein expression of the FHIT gene in the transfected cells was detected by RT-PCR and Western blot,respectively. The effect of FHIT on proliferation was detected by MTT assay. Changes in cell cycle and apoptosis were assayed by flow cytometry. Five mice received subcutaneous transplantation of Hep3B-FHIT;5 mice received subcutaneous transplantation of normal Hep3B and Hep3B-C as controls. The body weight of nude mice and tumor growth were measured. RESULTS:RT-PCR and Western blot analysis showed that the expression level of FHIT-mRNA and FHIT protein was higher in Hep3B cells after infection withpcDNA3.1(+) /FHIT. The growth of Hep3B cells treated with pcDNA3.1(+) /FHIT was significantly inhibited. The pcDNA3.1(+) /FHIT-transfected Hep3B cells showed a significantly higher cell rate at G0-G1 phase and increased apoptosis in comparison with controls(P < 0.05) . The growth of transplanted tumor was inhibited markedly by FHIT. Tumors arising from the Hep3B-FHIT cells occurred much later than those arising from the Hep3B and Hep3B-C cells. The growth of Hep3B-FHIT cells was slow and the tumor volume was low. CONCLUSION:Transduction of FHIT gene inhibits the growth of human hepatocellular carcinoma cells and induces cell apoptosis in vivo and in vitro. 展开更多
关键词 Hepatocellular carcinoma Gene therapy fragile histidine triad gene
下载PDF
Loss of fragile histidine triad protein expression in inflammatory bowel disease 被引量:2
6
作者 Chun-Mei Xu Chuan-Hu Qiao 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第45期7355-7360,共6页
AIM: To investigate the expression of fragile histidine triad (FHIT) protein in 64 patients with ulcerative colitis (UC) and Crohn's disease (CD), and its relation with clinicopathological data. METHODS: Rabb... AIM: To investigate the expression of fragile histidine triad (FHIT) protein in 64 patients with ulcerative colitis (UC) and Crohn's disease (CD), and its relation with clinicopathological data. METHODS: Rabbit-anti-FHIT antibody was used to detect FHIT protein expression in 64 formalin-fixed, paraffin-embedded tissue specimens of inflammatory bowel disease (IBD) by citrate-microwave-streptavidin (SP)-HRP immunohistochemical method. RESULTS: The positive FHIT protein expression was 22.79% ± 16.16%, 42.14% ± 16.82% in active and remittent phases of UC, 36.07% ± 19.23% in CD, and 57.05% ±8.86% in normal colon mucosa. Statistically significant differences in FHIT protein expression were observed between the active and remittent phases of UC, between the active phase of UC and normal colon mucosa, as well as between the remittent phase of UC and normal colon mucosa, and between CD and normal colon mucosa. CONCLUSION: Our results show that FHIT protein expression is completely absent or reduced in IBD, suggesting that the FHIT gene might be associated with the oncogenesis and progression of IBD, an early event from inflammatory conditions to carcinoma in IBD. 展开更多
关键词 fragile histidine triad protein expression Ulcerative colitis Crohn's disease Inflammatory bowel disease
下载PDF
EXPRESSION OF FRAGILE HISTIDINE TRIAD AND P53 IN NON-SMALL CELL LUNG CANCER
7
作者 侯兴华 张道荣 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2006年第2期121-126,共6页
Objective: To investigate the expression offragile histidine triad (FHIT) and p53 protein in non-small cell lung cancer (NSCLC) and explore the relationship between their expressions and the clinicopathological f... Objective: To investigate the expression offragile histidine triad (FHIT) and p53 protein in non-small cell lung cancer (NSCLC) and explore the relationship between their expressions and the clinicopathological features. Methods: FHIT protein and p53 protein were detected by immunohistochemistry in 76 cases of NSCLCs and matched normal lung tissues. Results: Fifty-one cases (67.1%) showed negative expression of FHIT (apparent reduction or loss) and thirty-seven cases (48.7%) showed p53 positive expression (overexpression). The difference was significant (P=0.04). However, there was no significant difference in FHIT expression between the p53-positive group and the p53-negative group (64.9% versus 69.2%, P=0.686). The negative rate of FHIT protein expression was higher in squamous cell carcinoma than in adenocarcinoma, in moderately and poorly differentiated carcinoma than in well-differentiated carcinoma, and in cases with smoking history than in cases without smoking history (P〈0.05). There was no relationship between FHIT expression and clinical stage or lymph node metastasis. The negative FHIT expression was not an independent predictor of overall survival (P=0.338). Conclusion: The frequency of negative expression of FHIT protein is higher than that of positive expression of p53 in NSCLCs. The negative expression of FHIT is independent of the expression of p53. The change of expression of FHIT may play a role in the smoking related lung tumorigenesis while it may have no relationship with the progress of NSCLC or prognosis of the patients. 展开更多
关键词 fragile histidine triad P53 Lung neoplasm Non-small cell lung cancer IMMUNOHISTOCHEMISTRY
下载PDF
Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors 被引量:9
8
作者 WANG Ou WANG Chun-yan +7 位作者 SHI Jie NIE Min XIA Wei-bo LI Mei JIANG Yan GUAN Heng MENG Xun-wu XING Xiao-ping 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第16期2895-2901,共7页
Background It is widely recognized that the diagnosis of parathyroid carcinoma (PC) is often difficult because of the overlap of characteristics between malignant and benign parathyroid tumors, especially at an earl... Background It is widely recognized that the diagnosis of parathyroid carcinoma (PC) is often difficult because of the overlap of characteristics between malignant and benign parathyroid tumors, especially at an early stage. Our study aimed to investigate the differential expression of Ki-67, galectin-3, fragile histidine triad (FHIT) gene, and parafibromin in PC, parathyroid adenoma (PA), parathyroid hyperplasia (PH), and normal parathyroid (NP) tissues; then to assess these expression values for use in differential diagnosis of malignant and benign parathyroid tumors. Methods Data of 15 cases with PC, 19 PAs, and 8 PHs were retrospectively analyzed for their clinical characteristics. The expression of Ki-67, galectin-3, FHIT, and parafibromin were detected via immunohistochemistry in the above-mentioned specimens and 6 NPs as control. Results Complete loss of parafibromin expression was seen in 9 of 15 (60%) carcinomas, and all normal parathyroid tissues and parathyroid benign tumors stained positive for parafibromin except for one (4%) adenoma. Galectin-3 staining was positive in 11 of 15 (73%) carcinomas, 5 of 19 (26%) adenomas, 1 of 8 (12%) hyperplasias, and 0 of 6 normal tissues. The Ki-67 proliferative index was high in 4 of 15 (27%) carcinomas, 1 of 19 (5%) adenomas, and none of the hyperplasia or normal tissues. FHIT expression did not differ appreciably among the tumor types. The combination of overexpression of galectin-3 or loss of parafibromin increased sensitivity for PC to 87%, while the specificity of both positive galectin-3 and positive Ki-67 could reach 100%. Conclusions These data suggested that loss of parafibromin and overexpression of galectin-3 and Ki-67 might help to distinguish parathyroid carcinoma from other parathyroid tumors. And the combination of two or three of these markers might produce better sensitivity and/or specificity for the diagnosis of parathyroid carcinoma. 展开更多
关键词 parathyroid tumors Ki-67 galectin-3 PARAFIBROMIN fragile histidine triad gene
原文传递
Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea 被引量:2
9
作者 Chang Woo Nam Jung Woo Shin Neung Hwa Park 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第22期3526-3533,共8页
AIM: To establish the role of FHIT in the pathogenesis hepatocellular carcinoma (HCC). METHODS: We examined genomic alterations, as well as, mRNA and protein expression patterns from the FHIT gene, in 48 surgically re... AIM: To establish the role of FHIT in the pathogenesis hepatocellular carcinoma (HCC). METHODS: We examined genomic alterations, as well as, mRNA and protein expression patterns from the FHIT gene, in 48 surgically resected hepatocellular carcinoma (HCC) tissues. Additionally, p53 mutations were analyzed. RESULTS: Aberrant FHIT transcripts were detected in 11 of 48 surrounding non-tumor liver tissues and 27 of 48 HCC samples (22.9% vs 56.3%, P = 0.002). No point mutations were identified within the open reading frame region of FHIT. Loss of heterozygosity (LOH) of the FHIT locus was detected in 4 of 42 informative cases for D3S1300, and 3 of 29 informative cases for D3S1313. Reduced expression of FHIT protein (Fhit) was observed in 8 (16.7%) of 48 HCC samples, with complete loss of Fhit in only 1 case. There were no associations with abnormal transcripts, LOH, and Fhit expression. p53 mutations were identified in 9 of the 48 HCC cases. However, none of the cases displayed a G to T transversion at p53 codon 249. CONCLUSION: Aberrant FHIT transcripts were more common in HCC tissues as compared to non-cancerous liver tissues. However, Fhit expression was lost or reduced in a minor fraction of HCC tissues, while it was strongly expressed in non-cancerous liver tissues.Therefore, our study suggests that FHIT plays a role in relatively few HCC cases in South Korea. 展开更多
关键词 fragile histidine triad Aberrant transcripts Microsatellite instability Protein expression Hepatocellular carcinoma
下载PDF
脆性组氨酸三联体基因甲基化与前列腺癌的相关性及临床意义
10
作者 罗荣利 张春霆 徐旻 《中国中西医结合外科杂志》 CAS 2024年第3期324-327,共4页
目的:检测前列腺癌患者血清中脆性组氨酸三联体基因(fragile histidine triad,FHIT)甲基化状态,探讨FHIT甲基化与前列腺癌患者临床病理特征及5年生化复发和临床进展之间的关系。方法:采用MSP法检测78例前列腺癌和45例前列腺增生患者血清... 目的:检测前列腺癌患者血清中脆性组氨酸三联体基因(fragile histidine triad,FHIT)甲基化状态,探讨FHIT甲基化与前列腺癌患者临床病理特征及5年生化复发和临床进展之间的关系。方法:采用MSP法检测78例前列腺癌和45例前列腺增生患者血清中FHIT甲基化表达状态,分析FHIT甲基化率与前列腺癌患者临床病理的关系,采用Kaplan-Meier生存分析FHIT甲基化率与前列腺癌5年生化复发和5年临床进展之间的关系。结果:前列腺癌患者血清中FHIT基因甲基化率为48.72%,高于前列腺增生患者的4.44%,差异有显著意义(PP<0.05)。FHIT甲基化与前列腺癌患者年龄、术前前列腺特异抗原(PSA)、TNM分期、Gleason分级有关;在前列腺癌Gleason分级≤7和Gleason 8~10分级中,FHIT甲基化率分别为59.18%和31.03%,在Ⅰ~Ⅱ期和Ⅲ~Ⅳ期前列腺癌患者中,FHIT甲基化率分别为37.50%和66.67%,差异有统计学意义(P<0.05)。甲基化组5年复发率和5年累计临床进展率高于非甲基化组(P<0.05)。结论:FHIT甲基化与前列腺癌临床病理有关,检测FHIT甲基化状态有助于评估前列腺癌患者的临床预后。 展开更多
关键词 前列腺癌 脆性组氨酸三联体基因 生化复发 肿瘤进展
下载PDF
EGFR Mutation and FHIT Methylation: Inverse Relationship in Patients with Lung Adenocarcinoma and Tuberculosis
11
作者 Mireguli Abudureheman Xiuyou Yan Baidurula Ainitu 《Proceedings of Anticancer Research》 2024年第2期65-72,共8页
Objective:To investigate the genetic correlations between epithelial growth factor receptor(EGFR)mutation and FHIT methylation in patients diagnosed with lung adenocarcinoma(AC)and pulmonary tuberculosis(TB).Methods:T... Objective:To investigate the genetic correlations between epithelial growth factor receptor(EGFR)mutation and FHIT methylation in patients diagnosed with lung adenocarcinoma(AC)and pulmonary tuberculosis(TB).Methods:The presence of EGFR mutations and the methylation status of the FHIT gene in patients presenting with AC and TB were analyzed.The correlation between TB status and the observed genetic and epigenetic variations was also examined.Results:Among the 90 patients included in the study,38 exhibited EGFR mutations(14 among those with TB and 24 among those without TB),while 29 exhibited FHIT myelination(19 among those with TB and 10 among those without TB).Furthermore,the protein expression levels of EGFR and FHIT were significantly higher in patients diagnosed solely with AC compared to those presenting with both AC and TB.A robust inverse correlation was identified between TB status and the frequency of EGFR mutation(P<0.001).Moreover,significant associations were observed between TB status and FHIT methylation(P<0.01).Conclusion:The findings suggest a correlation between TB and the prevalence of EGFR mutation and FHIT methylation in the pathogenesis of AC. 展开更多
关键词 Lung cancer Adenocarcinoma(AC) Tuberculosis(TB) Epithelial growth factor receptor(EGFR) fragile histidine triad(FHIT)
下载PDF
河北省磁县食管癌高发区食管鳞状细胞癌组织HPV检测及FHIT表达的研究 被引量:16
12
作者 刘艳丽 李学民 +6 位作者 靳国梁 严霞 杨建柱 王俊灵 李月红 王凤荣 张祥宏 《癌症》 SCIE CAS CSCD 北大核心 2003年第5期492-495,共4页
背景与目的:河北省磁县是食管癌高发区,有关人乳头状瘤病毒(humanpapillomavirus,HPV)感染和当地食管癌发生的关系尚无研究报道。本研究旨在探讨HPV感染在当地食管癌发生中的病因学意义,同时分析与环境致癌物密切相关的脆性组氨酸三联... 背景与目的:河北省磁县是食管癌高发区,有关人乳头状瘤病毒(humanpapillomavirus,HPV)感染和当地食管癌发生的关系尚无研究报道。本研究旨在探讨HPV感染在当地食管癌发生中的病因学意义,同时分析与环境致癌物密切相关的脆性组氨酸三联体基因(fragilehistidinetriad,FHIT)表达与HPV感染的关系。方法:收集河北省磁县食管癌高发区128例和非高发区24例食管鳞状细胞癌石蜡包埋组织,用PCR进行HPV检测,用免疫组化方法分析FHIT在蛋白水平上的表达情况,同时分析HPV感染和FHIT异常表达的关系。结果:PCR检测结果表明,河北省食管癌高发区食管鳞状细胞癌组织中HPV检出率为20.3%,略高于非高发区(8.3%),但两者差别无显著性(P>0.05)。免疫组化结果显示,食管癌高发区食管鳞癌组织中FHIT基因异常表达率(75.6%)明显高于非高发区食管鳞癌组织(54.2%,P<0.05)。食管癌组织中HPV感染和FHIT的异常表达之间无明显相关性。结论:河北省食管癌高发区食管癌组织FHIT的异常表达率明显高于非高发区病例。 展开更多
关键词 河北 食管癌 高发区食管鳞状细胞癌组织 HPV 检测 FHIT 表达 研究
下载PDF
FHIT和MDM2在口腔黏膜下纤维性变及其癌变组织中的表达 被引量:10
13
作者 尹晓敏 温春燕 +2 位作者 韩玉玲 高义军 唐瞻贵 《中南大学学报(医学版)》 CAS CSCD 北大核心 2010年第6期572-575,共4页
目的:初步探讨脆性组氨酸三联体基因(fragile histidine triad,FHIT)、原癌基因MDM2在口腔黏膜下纤维性变(oral submucous fibrosis,OSF)和癌变过程中的作用。方法:采用免疫组织化学SP法检测44例OSF组织、15例OSF癌变组织及10例正常口... 目的:初步探讨脆性组氨酸三联体基因(fragile histidine triad,FHIT)、原癌基因MDM2在口腔黏膜下纤维性变(oral submucous fibrosis,OSF)和癌变过程中的作用。方法:采用免疫组织化学SP法检测44例OSF组织、15例OSF癌变组织及10例正常口腔黏膜组织中FHIT和MDM2蛋白的表达及分布。结果:FHIT在正常口腔黏膜中强阳性表达,在OSF及OSF癌变组织中阳性表达率逐渐减少,OSF组及OSF癌变组织组显著低于正常对照组(P<0.05);OSF癌变组织组显著低于OSF组(P<0.05)。MDM2蛋白在正常口腔黏膜中呈阴性表达,在OSF及OSF癌变组织中阳性表达率逐渐增加,OSF组及OSF癌变组织组显著高于正常对照组(P<0.05),OSF癌变组织组显著高于OSF组(P<0.05)。结论:FHIT表达下调和缺失,以及MDM2过度表达可能在OSF癌变过程中具有重要作用。 展开更多
关键词 口腔黏膜下纤维性变 癌变 脆性组氨酸三联体基因 MDM2 免疫组织化学
下载PDF
喉鳞癌组织中FHIT表达与细胞增殖、转移的关系 被引量:12
14
作者 殷德涛 卢秀波 +2 位作者 董明敏 邱新光 王庆兆 《癌症》 SCIE CAS CSCD 北大核心 2004年第11期1338-1341,共4页
背景与目的:脆性组氨酸三联体(fragilehistidinetriad,FHIT)基因定位于染色体3pl4.2,跨越大多数人类基因组的共同脆性部位FRA3B,为一候选的抑癌基因,在包括头颈部鳞状细胞癌在内的许多人类恶性肿瘤中都存在FHIT基因的异常。本研究的目... 背景与目的:脆性组氨酸三联体(fragilehistidinetriad,FHIT)基因定位于染色体3pl4.2,跨越大多数人类基因组的共同脆性部位FRA3B,为一候选的抑癌基因,在包括头颈部鳞状细胞癌在内的许多人类恶性肿瘤中都存在FHIT基因的异常。本研究的目的为探讨喉鳞癌(laryngealsquamouscellcarcinoma,LSCC)组织中FHIT基因蛋白的表达及其与肿瘤细胞增殖与转移的关系。方法:采用免疫组化S法,检测41例喉鳞癌组织及其相对应的喉切缘非癌组织中FHIT、PCNA的表达。结果:非癌组织和喉鳞癌组织中,FHIT阳性率分别为100%(41/41)和46.3%(1941)(P<0.01)。喉鳞癌中,在TNM分期Ⅰ~Ⅱ期和Ⅲ~Ⅳ期组,FHIT阳性率分别为69.6%和16.7%;淋巴结转移阳性和阴性组分别为20.0%和61.5%。以上两组比较均有显著性差异(P<0.05)。非癌和喉鳞癌组织中,PCNA标记指数分别为(9.98±2.34)%和(50.71±13.64)%,两者有极显著性差异(P<0.01)。喉鳞癌中,FHIT与PCNA表达有明显的负相关关系(P<0.05)。结论:FHIT低表达与喉鳞癌细胞增殖及淋巴结转移有关。 展开更多
关键词 脆性组氨酸三联体基因 增殖细胞核抗原 喉肿瘤 鳞状细胞癌 免疫组化
下载PDF
宫颈癌组织中FHIT基因5'端CpG岛甲基化及其与基因失活的关系 被引量:20
15
作者 史惠蓉 吴庆华 +1 位作者 索振河 Jahn M Nesland 《癌症》 SCIE CAS CSCD 北大核心 2005年第1期7-11,共5页
背景与目的:脆性组氨酸三联基因(fragile histidine triad gene,FHIT)作为抑癌基因与多种实体瘤的发生有关,并在多种肿瘤中因甲基化而失活。本研究拟探讨宫颈癌组织中FHIT基因5'端CpG岛甲基化状况及其与基因失活的关系。方法:采用... 背景与目的:脆性组氨酸三联基因(fragile histidine triad gene,FHIT)作为抑癌基因与多种实体瘤的发生有关,并在多种肿瘤中因甲基化而失活。本研究拟探讨宫颈癌组织中FHIT基因5'端CpG岛甲基化状况及其与基因失活的关系。方法:采用甲基化特异性聚合酶链反应(methylation鄄specificPCR,MSP)和免疫组织化学法分别检测10例正常宫颈鳞状上皮、40例宫颈癌组织中FHIT基因5'端CpG岛的甲基化发生状况和FHIT蛋白表达情况。结果:(1)正常宫颈鳞状上皮组织中未发现存在FHIT基因甲基化状态,而宫颈癌组织中FHIT基因5'端CpG岛的甲基化率为40.0%(16/40);(2)临床Ⅱ期宫颈癌病例中FHIT基因甲基化的发生率为56.5%(13/23),明显高于Ⅰ期的14.3%(2/14)(P<0.05);(3)宫颈癌组织中存在FHIT蛋白表达降低或缺失,阳性率仅为30.0%(12/40),显著低于正常宫颈组织的100.0%(10/10)(P<0.05)。结论:FHIT基因5'端CpG岛甲基化是宫颈癌中该基因失活的机制之一,可能与宫颈癌的发生发展有关。 展开更多
关键词 宫颈肿瘤 FHIT基因 甲基化 甲基化特异性PCR 免疫组织化学
下载PDF
脆性组氨酸三聚体基因及错配修复基因hMLH_1在口腔鳞状细胞癌中的表达及意义 被引量:7
16
作者 谷建琦 张英怀 +3 位作者 杨威 张杰英 蒋崇槟 贾志宇 《第三军医大学学报》 CAS CSCD 北大核心 2007年第2期151-153,共3页
目的探讨脆性组氨酸三聚体基因(fragilehistidinetriad,FHIT)和hMLH1基因在口腔鳞状细胞癌组织中的表达及其相互关系。方法采用免疫组化法检测69例口腔鳞状细胞癌和40例正常口腔黏膜组织中FHIT和hMLH1的表达情况。资料的统计学处理用SPS... 目的探讨脆性组氨酸三聚体基因(fragilehistidinetriad,FHIT)和hMLH1基因在口腔鳞状细胞癌组织中的表达及其相互关系。方法采用免疫组化法检测69例口腔鳞状细胞癌和40例正常口腔黏膜组织中FHIT和hMLH1的表达情况。资料的统计学处理用SPSS软件完成,比较用χ2检验。结果口腔鳞状细胞癌组织中FHIT、hMLH1的阳性表达率(46.4%,47·8%)低于正常口腔黏膜组织(77.5%,77.5%),有显著性差异(P<0·05)。结论FHIT和hMLH1可能在口腔鳞状细胞癌的发生发展中发挥重要作用。 展开更多
关键词 口腔鳞状细胞癌 脆性组氨酸三聚体 错配修复基因HMLH1 免疫组织化学
下载PDF
^(60)Coγ射线照射对人脆性组胺酸基因表达的影响 被引量:4
17
作者 熊杰 韩玲 +1 位作者 高伟 朱丹 《第二军医大学学报》 CAS CSCD 北大核心 2005年第5期471-475,共5页
目的研究人脆性组胺酸三联体(fragilehistidinetriad,FHIT)基因在电离辐射损伤过程中的动态变化。方法以SV40病毒转染的永生化人支气管上皮细胞株BEAS2B细胞为照射对象,分为0.5、1、2、4、8、16Gy60Coγ射线照射剂量组和未照射对照组,... 目的研究人脆性组胺酸三联体(fragilehistidinetriad,FHIT)基因在电离辐射损伤过程中的动态变化。方法以SV40病毒转染的永生化人支气管上皮细胞株BEAS2B细胞为照射对象,分为0.5、1、2、4、8、16Gy60Coγ射线照射剂量组和未照射对照组,分别于照射后24h、72h和10d,采用单细胞RT PCR技术以及PCR产物直接测序法检测FHIT基因的表达情况。结果对照组各时间点均未检出异常FHIT转录本,不同剂量照射组照射后各时间点均不同程度检出异常缺失FHIT转录本,照射后24h各组突变百分比分别为52.6%、66.7%、57.9%、76.5%、64.7%和81.3%,照射后72h各组突变百分比分别为17.6%、22.2%、50.0%、47.4%、47.1%和68.4%,照射后10d各组突变百分比分别为21.1%、25.0%、60.0%、57.9%、61.1%和68.4%;突变体经测序证实为外显子缺失性突变。结论电离辐射可引起FHIT基因的缺失突变。 展开更多
关键词 ^60COΓ射线照射 基因表达 脆性组胺酸三联体 FHIT基因 电离辐射 上皮细胞株 直接测序法 PCR产物 PCR技术 动态变化 损伤过程 病毒转染 SV40 照射剂量 表达情况 不同程度 不同剂量 缺失突变 对照组 24h 72h 转录本 B细胞
下载PDF
肺癌中FHIT基因异常甲基化及其蛋白表达的意义 被引量:4
18
作者 杨志慧 刘惠敏 +3 位作者 何金 王良哲 孙静 陈兵 《肿瘤》 CAS CSCD 北大核心 2007年第11期902-906,共5页
目的:检测肺癌组织FHIT蛋白表达及基因异常甲基化,探讨其在肺癌发生发展中的作用。方法:应用免疫组化SP法和甲基化特异性PCR(MSP)检测肺癌组织与癌旁组织(n=60)中FHIT蛋白表达和基因异常甲基化情况,并对基因甲基化扩增产物进行测序,对6... 目的:检测肺癌组织FHIT蛋白表达及基因异常甲基化,探讨其在肺癌发生发展中的作用。方法:应用免疫组化SP法和甲基化特异性PCR(MSP)检测肺癌组织与癌旁组织(n=60)中FHIT蛋白表达和基因异常甲基化情况,并对基因甲基化扩增产物进行测序,对60例患者随访调查。结果:FHIT蛋白在癌旁组织的阳性表达明显高于癌组织,二者差异存在统计学意义(76.7%vs50.0%,P<0.05);FHIT基因异常甲基化在癌组织中的发生率明显高于癌旁组织,二者差异存在统计学意义(68.3%vs35.0%,P<0.001);FHIT基因甲基化的发生率在FHIT蛋白阴性患者中高于阳性表达者(83.3%vs53.5%,P<0.05);FHIT蛋白表达及基因甲基化发生率均与性别、年龄、吸烟状况、组织学类型、大体分型、TNM分期及淋巴结转移无关(P>0.05);FHIT蛋白阳性表达患者生存率高于阴性表达者(P<0.05),FHIT蛋白是影响无瘤生存时间的危险因素(P<0.001)。结论:肺癌中FHIT基因异常甲基化频繁发生,FHIT蛋白表达明显下调,FHIT在肺癌的发生发展中可能具有重要的作用,FHIT蛋白可以作为判断患者预后的重要指标。 展开更多
关键词 肺肿瘤 脆性组氨酸三联体 DNA甲基化 基因表达
下载PDF
FHIT蛋白在人脑胶质瘤组织中的表达及临床意义 被引量:4
19
作者 寿记新 王新军 +3 位作者 吴建珩 单峤 李培栋 刘泉 《山东医药》 CAS 北大核心 2006年第32期18-19,共2页
目的探讨人脑胶质瘤组织脆性组胺三联体(FH IT)的表达及其临床意义。方法应用免疫组织化学SP法,检测38例人脑胶质瘤组织(观察组;低度恶性13例,高度恶性25例)和8例正常脑组织(对照组)中FH IT蛋白的表达。结果观察组FH IT蛋白表达率(47.4%... 目的探讨人脑胶质瘤组织脆性组胺三联体(FH IT)的表达及其临床意义。方法应用免疫组织化学SP法,检测38例人脑胶质瘤组织(观察组;低度恶性13例,高度恶性25例)和8例正常脑组织(对照组)中FH IT蛋白的表达。结果观察组FH IT蛋白表达率(47.4%)明显低于对照组(100%),P<0.01;低度恶性者FH IT蛋白表达率(53.8%)明显高于高度恶化者(44.0%),P<0.05。结论FH IT的异常表达与人脑胶质瘤的发生、发展有关。 展开更多
关键词 胶质瘤 脆性组胺三联体 免疫组织化学 抑癌基因
下载PDF
FHIT和Ki-67在CIN、宫颈癌中的表达及意义 被引量:8
20
作者 周菊梅 吴宜林 +2 位作者 刘凤英 王欢华 张志胜 《实用妇产科杂志》 CAS CSCD 北大核心 2005年第9期557-559,共3页
目的:探讨脆性组氨酸三联体(FHIT)和Ki67在宫颈上皮内瘤样病变(CIN)和宫颈癌中的表达情况。方法:采用免疫组化检测二者在正常和病变宫颈组织中的表达。结果:①FHIT的异常表达率和Ki67LI随着宫颈肿瘤的进展逐渐增加。②Ki67与宫颈癌的组... 目的:探讨脆性组氨酸三联体(FHIT)和Ki67在宫颈上皮内瘤样病变(CIN)和宫颈癌中的表达情况。方法:采用免疫组化检测二者在正常和病变宫颈组织中的表达。结果:①FHIT的异常表达率和Ki67LI随着宫颈肿瘤的进展逐渐增加。②Ki67与宫颈癌的组织学级别、肌层浸润和淋巴结转移有关。③FHIT在宫颈癌中的表达与Ki67不相关。结论:①FHIT和Ki67与宫颈癌的发生发展有关。②FHIT可能不参与细胞周期的调控。 展开更多
关键词 宫颈肿瘤 脆性组氨酸三联体 核抗原Ki-67
下载PDF
上一页 1 2 13 下一页 到第
使用帮助 返回顶部